Boxer Capital, LLC Voyager Therapeutics, Inc. Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $6.41 Million - $8.43 Million	-500,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $6.52 Million - $11.3 Million	400,000 Added 400.0%	500,000 $8.61 Million
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $1.92 Million - $2.79 Million	100,000 New	100,000 $2.72 Million

128

36.7M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.